MBRX

Moleculin Biotech Inc.

Price

$0.77

return (12m)

-92.32%

p/e

-0.11

p/bv

0.38

DIVIDEND YIELD

0.00%

MBRX price

Moleculin Biotech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MBRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

29.13%

3 months

-75.22%

1 year

-92.32%

2 years

-98.70%

5 years

-99.93%

10 years

-99.99%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MBRX

Valuation

P/E

-0.11

Sector -3.50

Industry -3.50

P/BV

0.38

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

0.38

Sector -214.99

Industry -214.99

EV/EBIT

0.38

Sector -47.59

Industry -47.59

P/EBITDA

-0.15

Sector -21.41

Industry -21.41

P/EBIT

-0.15

Sector -28.65

Industry -28.65

P/Total Assets

0.21

Sector 1.19

Industry 1.19

P/Net Current Assets

-5.67

Sector -11.97

Industry -11.97

P/Working Capital

-7.46

Sector -167.95

Industry -167.95

EPS

-7.13

Sector -1.81

Industry -1.81

BVPS

2.04

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-349.50%

Sector -56.04%

Industry -56.04%

ROA

-192.04%

Sector -60.31%

Industry -60.31%

ROIC

-241.45%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.94

Sector 2.89

Industry 2.89

Net Debt / EBITDA

0.96

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

0.96

Sector -8.06

Industry -8.06

Net Debt / Equity

-0.63

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.55

Sector 0.46

Industry 0.46

Liabilities/Assets

0.45

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

20.57%

Sector -

Industry -

Fundamentals MBRX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MBRX Moleculin Biotech Inc.	$0.77	-92.32%	0.00%	-0.11	0.38	-349.50%	0.00%
JNJ Johnson & Johnson	$269.99	56.71%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.66	23.21%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.96	22.44%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.24	-26.07%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.87	87.26%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.08	10.74%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.06	48.20%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$71.40	-50.11%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$385.65	38.85%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.85	33.10%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$112.45	44.52%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.65	25.89%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$508.34	32.68%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$225.38	52.58%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$990.32	34.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.02	29.13%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MBRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Moleculin Biotech

Moleculin Biotech Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2016

Time since IPO - 10 years

15

Employees

Moleculin Biotech Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.40 million, with shareholders equity totaling $11.59 million.

The company employs approximately 15 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Moleculin Biotech Inc. reported $- in revenue, generating net income of $-40.50 million.

Key financial metrics include a P/E ratio of -0.11, a price-to-book (P/B) ratio of 0.38, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MBRX.

Market cap

$4.40 million

Net worth

$11.59 million

$11,587,000.00

Assets

$21.09 million

$21,087,000.00

Total Shares Outstanding

5.68 million

5,680,000

Average Daily Trading Volume

$1.23 million

$1,232,956.58

Sector

Health Care

Industry

Biotechnology

MBRX

MBRX revenue and profits

Financial Results MBRX

DRAG THE FRAME TO SEE MORE DATA

MBRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.65 25,89% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$225.38 52,58% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.96 22,44% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.87 87,26% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.08 9,00% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.66 23,21% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.65 25,89% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$225.38 52,58% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.96 22,44% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.87 87,26% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.08 9,00% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.66 23,21% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Moleculin Biotech (MBRX) today?

A cotação de Moleculin Biotech (MBRX) hoje está em US$ 0.77, com uma variação de -92.32% em relação ao último ano. A cotação de Moleculin Biotech (MBRX) iniciou o ano negociando na casa dos US$ 3.31 e hoje está em US$ 0.77. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Moleculin Biotech (MBRX) e dados de ações do Ibovespa e mercados internacionais.

Quando Moleculin Biotech (MBRX) paga dividendos?

Moleculin Biotech (MBRX) não distribuiu dividendos no último ano.

Is Moleculin Biotech (MBRX) a good investment?

Atualmente, Moleculin Biotech (MBRX) está cotada a US$ 0.77, com um P/L de -0.11, representando um desvio de -7,972% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -92.32 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -92.32%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Moleculin Biotech (MBRX) stock?

Investir em ações de Moleculin Biotech (MBRX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Moleculin Biotech (MBRX) yield today?

A rentabilidade de Moleculin Biotech (MBRX) foi de 29.13% no último mês, -92.32% no último ano e -99.93% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Moleculin Biotech (MBRX) hoje, o investimento total seria de US$ 77.31, com base na cotação atual de US$ 0.77.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 5.94
Em 5 anos: US$ 0.05
Em 10 anos: US$ 0.007731

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MBRX

Moleculin Biotech Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MBRX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MBRX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Moleculin Biotech

Moleculin Biotech Inc.

United States

11 years

2016

15

PROFIT X PRICE MBRX

Financial Results MBRX

MBRX cash flow

Asset, Revenue and Profit Growth - MBRX

MBRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions